CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 242 filers reported holding CYTOKINETICS INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,250,000 | -24.4% | 251,287 | -6.4% | 0.01% | -16.7% |
| Q4 2021 | $12,242,000 | +33.4% | 268,586 | +4.6% | 0.01% | +20.0% |
| Q3 2021 | $9,174,000 | +169.0% | 256,690 | +48.9% | 0.01% | +150.0% |
| Q2 2021 | $3,411,000 | -12.0% | 172,383 | +3.5% | 0.00% | 0.0% |
| Q1 2021 | $3,875,000 | +19.4% | 166,605 | +6.7% | 0.00% | 0.0% |
| Q4 2020 | $3,246,000 | -2.8% | 156,209 | +1.2% | 0.00% | 0.0% |
| Q3 2020 | $3,341,000 | -24.6% | 154,316 | -17.9% | 0.00% | -33.3% |
| Q2 2020 | $4,430,000 | +206.4% | 187,961 | +53.3% | 0.00% | +200.0% |
| Q1 2020 | $1,446,000 | +35.0% | 122,613 | +21.5% | 0.00% | 0.0% |
| Q4 2019 | $1,071,000 | -19.1% | 100,933 | -13.3% | 0.00% | 0.0% |
| Q3 2019 | $1,324,000 | +12.6% | 116,353 | +11.3% | 0.00% | 0.0% |
| Q2 2019 | $1,176,000 | +84.6% | 104,570 | +32.7% | 0.00% | 0.0% |
| Q1 2019 | $637,000 | +22.7% | 78,787 | -4.0% | 0.00% | 0.0% |
| Q4 2018 | $519,000 | -13.6% | 82,054 | +34.4% | 0.00% | 0.0% |
| Q3 2018 | $601,000 | +110.9% | 61,030 | +77.5% | 0.00% | – |
| Q2 2018 | $285,000 | -12.8% | 34,379 | -24.4% | 0.00% | – |
| Q1 2018 | $327,000 | +59.5% | 45,468 | +80.4% | 0.00% | – |
| Q4 2017 | $205,000 | -61.9% | 25,205 | -32.0% | 0.00% | -100.0% |
| Q3 2017 | $538,000 | +93.5% | 37,087 | +61.1% | 0.00% | – |
| Q2 2017 | $278,000 | +62.6% | 23,015 | +72.6% | 0.00% | – |
| Q1 2017 | $171,000 | +6.9% | 13,333 | +1.4% | 0.00% | – |
| Q4 2016 | $160,000 | +32.2% | 13,144 | -0.4% | 0.00% | – |
| Q3 2016 | $121,000 | -10.4% | 13,200 | -7.0% | 0.00% | – |
| Q2 2016 | $135,000 | -72.3% | 14,196 | -79.5% | 0.00% | -100.0% |
| Q1 2016 | $487,000 | +81.0% | 69,121 | +168.8% | 0.00% | – |
| Q4 2015 | $269,000 | +122.3% | 25,716 | +41.9% | 0.00% | – |
| Q3 2015 | $121,000 | +4.3% | 18,122 | +4.6% | 0.00% | – |
| Q2 2015 | $116,000 | -1.7% | 17,318 | -0.2% | 0.00% | – |
| Q1 2015 | $118,000 | 0.0% | 17,352 | +17.8% | 0.00% | – |
| Q4 2014 | $118,000 | – | 14,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |